How many bone metastases may be defined as high‐volume metastatic prostate cancer in Asians: A retrospective multicenter cohort study-Reference-Cited by-同舟云学术

How many bone metastases may be defined as high‐volume metastatic prostate cancer in Asians: A retrospective multicenter cohort study

Published:2020-02-03 Issue:5 Volume:80 Page:432-440
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Yamada Yasutaka¹^ORCID,Sakamoto Shinichi¹^ORCID,Rii Junryo¹,Yamamoto Satoshi¹,Kamada Shuhei¹,Imamura Yusuke¹,Nakamura Kazuyoshi¹,Komiya Akira¹,Nakatsu Hiroomi²,Ichikawa Tomohiko¹

Affiliation:

1. Department of UrologyChiba University Graduate School of MedicineChiba Japan

2. Department of UrologyAsahi General HospitalAsahi Japan

Funder

KAKENHI grant

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23958

Reference29 articles.

1. The Diagnosis and Treatment of Prostate Cancer

2. Cancer statistics, 2017

3. Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer

4. Newly Diagnosed Metastatic Prostate Cancer: Has the Paradigm Changed?

5. Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cinobufotalin Capsule Combined with Zoledronic Acid in the Treatment of Pain Symptoms and Clinical Efficacy in Prostate Cancer Patients with Bone Metastases: A Retrospective Study;Archivos Españoles de Urología;2024

2. Clinical utility of the prognostic nutritional index in patients with metastatic hormone‐sensitive prostate cancer: A retrospective, multicenter, cohort study;The Prostate;2023-09-10

3. Development and validation of a novel risk model in newly diagnosed de novo bone metastatic prostate cancer (M1b): a retrospective study;PeerJ;2023-01-12

4. Clinical utility of intraductal carcinoma of the prostate in treatment selection for metastatic hormone‐sensitive prostate cancer;The Prostate;2022-11-24

5. Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases;Strahlentherapie und Onkologie;2022-06-15